10x Genomics
TXG
TXG
328 hedge funds and large institutions have $11.5B invested in 10x Genomics in 2021 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 115 increasing their positions, 105 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
328
Holders Change
-10
Holders Change %
-2.96%
% of All Funds
5.76%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.14%
New
44
Increased
115
Reduced
105
Closed
51
Calls
$32.4M
Puts
$75.8M
Net Calls
-$43.4M
Net Calls Change
-$101M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$254M |
| 2 |
BlackRock
New York
|
+$117M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$76.4M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$74.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$68.1M |
Top Sellers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$174M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$95.6M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
-$65.4M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$53M |
| 5 |
Goldman Sachs
New York
|
-$46.2M |
